Nalidixic acid

Overview

Nalidixic acid, a quinolone antibiotic , is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria.

Application

Products | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Infection | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Topoisomerase

Product Information

• Catalog No.: HY-B0398
• CAS No.: 389-08-2
• Molecular Formula: C12H12N2O3
• Molecular Weight: 232.24
• Purity: 99.97%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 0.5 mg/mL (2.15 mM); Clear solution
• Availability: In-stock

Source

Original product source